Phio Pharmaceuticals Dividends and Buybacks
Dividend criteria checks 0/6
Phio Pharmaceuticals does not have a record of paying a dividend.
Key information
n/a
Dividend yield
-246.2%
Buyback Yield
| Total Shareholder Yield | -246.2% |
| Future Dividend Yield | n/a |
| Dividend Growth | n/a |
| Next dividend pay date | n/a |
| Ex dividend date | n/a |
| Dividend per share | n/a |
| Payout ratio | n/a |
Recent dividend and buyback updates
No updates
Recent updates
Phio Pharmaceuticals appoints interim executive chairman
Sep 29Phio Pharmaceuticals GAAP EPS of -$0.19 beats by $0.12
Aug 11Is Phio Pharmaceuticals (NASDAQ:PHIO) In A Good Position To Deliver On Growth Plans?
Apr 11
Phio soars 22% on positive in vivo data on combination PD-1 and TIGIT therapy in cancer
Nov 09Stability and Growth of Payments
Fetching dividends data
Stable Dividend: Insufficient data to determine if PHIO's dividends per share have been stable in the past.
Growing Dividend: Insufficient data to determine if PHIO's dividend payments have been increasing.
Dividend Yield vs Market
| Phio Pharmaceuticals Dividend Yield vs Market |
|---|
| Segment | Dividend Yield |
|---|---|
| Company (PHIO) | n/a |
| Market Bottom 25% (US) | 1.4% |
| Market Top 25% (US) | 4.3% |
| Industry Average (Biotechs) | 2.3% |
| Analyst forecast (PHIO) (up to 3 years) | n/a |
Notable Dividend: Unable to evaluate PHIO's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.
High Dividend: Unable to evaluate PHIO's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.
Earnings Payout to Shareholders
Earnings Coverage: Insufficient data to calculate PHIO's payout ratio to determine if its dividend payments are covered by earnings.
Cash Payout to Shareholders
Cash Flow Coverage: Unable to calculate sustainability of dividends as PHIO has not reported any payouts.